MeiraGTx
MeiraGTx is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 1 tracked investor.
About MeiraGTx
MeiraGTx is a startup based in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
MeiraGTx is a clinical-stage genetic medicine company developing AAV-based gene therapies and enabling technologies, including a riboswitch gene regulation platform and an end-to-end GMP manufacturing ecosystem, to treat inherited and non-inherited diseases (programs include xerostomia, retinal dystrophies and Parkinson’s disease).
Explore MeiraGTx's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.